Literature DB >> 28723317

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

Aidin Rawshani1,2, Araz Rawshani1, Soffia Gudbjörnsdottir1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28723317     DOI： 10.1056/NEJMc1706292

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

2.  2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; James L Januzzi; Rita R Kalyani; Mikhail Kosiborod; Melissa Magwire; Pamela B Morris; Joshua J Neumiller; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2020-08-05       Impact factor: 24.094

Review 3.  NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes.

Authors:  Marcus Vinicius Bolivar Malachias; Magnus Olof Wijkman; Marcello Casaccia Bertoluci
Journal:  Diabetol Metab Syndr       Date:  2022-05-03       Impact factor: 5.395

4.  The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials.

Authors:  Emilie H Zobel; Bernt Johan von Scholten; Tine W Hansen; Frederik Persson; Søren Rasmussen; Benjamin Wolthers; Peter Rossing
Journal:  Diabetes Obes Metab       Date:  2021-11-05       Impact factor: 6.408

5.  Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes.

Authors:  Resham L Gurung; M Yiamunaa; Sylvia Liu; Jian Jun Liu; Clara Chan; Robin Wai Munn Choo; Keven Ang; Chee Fang Sum; Subramaniam Tavintharan; Su Chi Lim
Journal:  Cardiovasc Diabetol       Date:  2019-05-30       Impact factor: 9.951

6.  An Observational Study of the Equivalence of Age and Duration of Diabetes to Glycemic Control Relative to the Risk of Complications in the Combined Cohorts of the DCCT/EDIC Study.

Authors:  Ionut Bebu; Barbara H Braffett; David Schade; William Sivitz; John I Malone; Rodica Pop-Busui; Gayle M Lorenzi; Pearl Lee; Victoria R Trapani; Amisha Wallia; William H Herman; John M Lachin
Journal:  Diabetes Care       Date:  2020-08-11       Impact factor: 19.112

Review 7.  Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom.

Authors:  Belinda S Lennerz; Andrew P Koutnik; Svetlana Azova; Joseph I Wolfsdorf; David S Ludwig
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 8.  RBPs Play Important Roles in Vascular Endothelial Dysfunction Under Diabetic Conditions.

Authors:  Chunbo Yang; Sophia Kelaini; Rachel Caines; Andriana Margariti
Journal:  Front Physiol       Date:  2018-09-20       Impact factor: 4.566

9.  Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis.

Authors:  S McGurnaghan; L A K Blackbourn; E Mocevic; U Haagen Panton; R J McCrimmon; N Sattar; S Wild; H M Colhoun
Journal:  Diabet Med       Date:  2018-10-10       Impact factor: 4.359

10.  Effect of hypoglycaemia on measures of myocardial blood flow and myocardial injury in adults with and without type 1 diabetes: A prospective, randomised, open-label, blinded endpoint, cross-over study.

Authors:  Radzi M Noh; Alex J Graveling; Ninian N Lang; Audrey C White; Kuan K Lee; Nicholas L Mills; David E Newby; Chim C Lang; Brian M Frier
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.